Physician profile
Michael Levin
NPI 1285922187
$13,663.57
in general payments reported to CMS, 2019-2025
45 companies · $6,683 in 2025
The $6,683 reported for 2025 was more than what 99% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $1,160 · 2021: $681 · 2022: $691 · 2023: $3,135 · 2024: $751 · 2025: $6,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,624 · Food and Beverage: $2,607 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,390 · Travel and Lodging: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,624.48 |
| Food and Beverage | $2,607.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,390.00 |
| Travel and Lodging | $947.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,624.50 | 2019-2025 | |
| Boston Scientific Corporation | $2,679.33 | 2019-2023 | Rezum Generator |
| Bayer Healthcare Pharmaceuticals INC. | $987.65 | 2020-2025 | |
| Astellas Pharma US INC | $708.30 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $496.77 | 2019-2025 | Erleada, Akeega |
| Olympus America INC. | $439.83 | 2021-2025 | Itind System |
| Sumitomo Pharma America, INC. | $288.88 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $276.97 | 2021-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $247.70 | 2021-2025 | Prolaris, Myrisk |
| Antares Pharma, INC. | $170.33 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Biotissue Holdings INC. | $120.11 | 2025 | |
| Janssen Scientific Affairs, LLC | $106.35 | 2019-2024 | Erleada, Pipeline |
| Blue Earth Diagnostics | $105.38 | 2020-2025 | Posluma |
| Abbvie INC. | $99.86 | 2023-2025 | |
| Amgen INC. | $93.17 | 2019 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $89.82 | 2021-2022 | |
| Pfizer INC. | $85.15 | 2021-2025 | |
| Procept Biorobotics Corporation | $82.62 | 2022-2023 | Aquabeam Robotic System |
| Coloplast Corp | $77.60 | 2019-2020 | |
| Smith+Nephew, INC. | $69.70 | 2019-2022 | |
| Photocure INC | $65.96 | 2021-2025 | Cysview |
| Profound Medical Corp. | $63.07 | 2025 | Tulsa-Pro |
| Avyxa Pharma, LLC | $55.15 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $52.85 | 2019-2021 | |
| 180 Medical, INC. | $42.97 | 2022-2023 | Cure Catheter |
| Teleflex LLC | $42.79 | 2025 | Barrigel |
| Tolmar, INC. | $42.08 | 2024-2025 | Eligard, Jatenzo |
| Avation Medical, INC. | $40.07 | 2025 | Vivally System |
| Srs Medical Systems, INC. | $38.91 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $36.38 | 2019 | |
| Laborie Medical Technologies Corp. | $36.00 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Accord Healthcare, INC. | $34.68 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $28.37 | 2024 | |
| Agiliti Surgical, INC. | $26.86 | 2023 | Sonablate, Trinity |
| Analogic Corporation | $26.55 | 2019 | |
| Urogen Pharma, INC. | $25.71 | 2021-2023 | Jelmyto |
| Merck Sharp & Dohme LLC | $22.94 | 2022 | |
| Foundation Medicine, INC. | $20.25 | 2023 | |
| Genzyme Corporation | $19.30 | 2022 | |
| Curium US LLC | $18.85 | 2023 | |
| Mimedx Group, INC. | $17.97 | 2025 | |
| Immunitybio, INC. | $16.64 | 2025 | |
| Allergan, INC. | $15.80 | 2020 | |
| Alnylam Pharmaceuticals INC. | $11.80 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.